BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 16863502)

  • 21. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China.
    Cao Z; Bai X; Guo X; Jin Y; Qian G; Tu H
    Arch Virol; 2008; 153(10):1807-12. PubMed ID: 18726170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
    Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
    J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma.
    Bläckberg J; Kidd-Ljunggren K
    J Med Virol; 2003 Sep; 71(1):18-23. PubMed ID: 12858404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
    Choi MS; Kim DY; Lee DH; Lee JH; Koh KC; Paik SW; Rhee JC; Yoo BC
    J Viral Hepat; 2007 Mar; 14(3):161-8. PubMed ID: 17305881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
    Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
    J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.
    Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH
    Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
    Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
    Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
    Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
    Lin X; Qian GS; Lu PX; Wu L; Wen YM
    J Med Virol; 2001 Jul; 64(3):299-304. PubMed ID: 11424118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
    Kao JH; Chen PJ; Chen DS
    Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
    Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
    Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy.
    Lai MW; Huang SF; Hsu CW; Chang MH; Liaw YF; Yeh CT
    Antivir Ther; 2009; 14(2):249-61. PubMed ID: 19430100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.